Pneumocystis jirovecii pneumonia in tropical and low and middle income countries: a systematic review and meta-regression.

Pneumocystis jirovecii pneumonia (PCP), the commonest opportunistic infection in HIV-infected patients in the developed world, is less commonly described in tropical and low and middle income countries (LMIC). We sought to investigate predictors of PCP in these settings.Systematic review and meta-re...

Full description

Bibliographic Details
Main Authors: David M Lowe, Molebogeng X Rangaka, Fabiana Gordon, Chris D James, Robert F Miller
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3732248?pdf=render
id doaj-be9a4073cb194a42a0171c08c6f7c03d
record_format Article
spelling doaj-be9a4073cb194a42a0171c08c6f7c03d2020-11-25T02:47:04ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0188e6996910.1371/journal.pone.0069969Pneumocystis jirovecii pneumonia in tropical and low and middle income countries: a systematic review and meta-regression.David M LoweMolebogeng X RangakaFabiana GordonChris D JamesRobert F MillerPneumocystis jirovecii pneumonia (PCP), the commonest opportunistic infection in HIV-infected patients in the developed world, is less commonly described in tropical and low and middle income countries (LMIC). We sought to investigate predictors of PCP in these settings.Systematic review and meta-regression.Meta-regression of predictors of PCP diagnosis (33 studies). Qualitative and quantitative assessment of recorded CD4 counts, receipt of prophylaxis and antiretrovirals, sensitivity and specificity of clinical signs and symptoms for PCP, co-infection with other pathogens, and case fatality (117 studies).The most significant predictor of PCP was per capita Gross Domestic Product, which showed strong linear association with odds of PCP diagnosis (p<0.0001). This was not explained by study design or diagnostic quality. Geographical area, population age, study setting and year of study also contributed to risk of PCP. Co-infection was common (444 episodes/1425 PCP cases), frequently with virulent organisms. The predictive value of symptoms, signs or simple tests in LMIC settings for diagnosis of PCP was poor. Case fatality was >30%; treatment was largely appropriate. Prophylaxis appeared to reduce the risk for development of PCP, however 24% of children with PCP were receiving prophylaxis. CD4 counts at presentation with PCP were usually <200×10(3/)ml.There is a positive relationship between GDP and risk of PCP diagnosis. Although failure to diagnose infection in poorer countries may contribute to this, we also hypothesise that poverty exposes at-risk patients to a wide range of infections and that the relatively non-pathogenic P. jirovecii is therefore under-represented. As LMIC develop economically they eliminate the conditions underlying transmission of virulent infection: P. jirovecii, ubiquitous in all settings, then becomes a greater relative threat.http://europepmc.org/articles/PMC3732248?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author David M Lowe
Molebogeng X Rangaka
Fabiana Gordon
Chris D James
Robert F Miller
spellingShingle David M Lowe
Molebogeng X Rangaka
Fabiana Gordon
Chris D James
Robert F Miller
Pneumocystis jirovecii pneumonia in tropical and low and middle income countries: a systematic review and meta-regression.
PLoS ONE
author_facet David M Lowe
Molebogeng X Rangaka
Fabiana Gordon
Chris D James
Robert F Miller
author_sort David M Lowe
title Pneumocystis jirovecii pneumonia in tropical and low and middle income countries: a systematic review and meta-regression.
title_short Pneumocystis jirovecii pneumonia in tropical and low and middle income countries: a systematic review and meta-regression.
title_full Pneumocystis jirovecii pneumonia in tropical and low and middle income countries: a systematic review and meta-regression.
title_fullStr Pneumocystis jirovecii pneumonia in tropical and low and middle income countries: a systematic review and meta-regression.
title_full_unstemmed Pneumocystis jirovecii pneumonia in tropical and low and middle income countries: a systematic review and meta-regression.
title_sort pneumocystis jirovecii pneumonia in tropical and low and middle income countries: a systematic review and meta-regression.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description Pneumocystis jirovecii pneumonia (PCP), the commonest opportunistic infection in HIV-infected patients in the developed world, is less commonly described in tropical and low and middle income countries (LMIC). We sought to investigate predictors of PCP in these settings.Systematic review and meta-regression.Meta-regression of predictors of PCP diagnosis (33 studies). Qualitative and quantitative assessment of recorded CD4 counts, receipt of prophylaxis and antiretrovirals, sensitivity and specificity of clinical signs and symptoms for PCP, co-infection with other pathogens, and case fatality (117 studies).The most significant predictor of PCP was per capita Gross Domestic Product, which showed strong linear association with odds of PCP diagnosis (p<0.0001). This was not explained by study design or diagnostic quality. Geographical area, population age, study setting and year of study also contributed to risk of PCP. Co-infection was common (444 episodes/1425 PCP cases), frequently with virulent organisms. The predictive value of symptoms, signs or simple tests in LMIC settings for diagnosis of PCP was poor. Case fatality was >30%; treatment was largely appropriate. Prophylaxis appeared to reduce the risk for development of PCP, however 24% of children with PCP were receiving prophylaxis. CD4 counts at presentation with PCP were usually <200×10(3/)ml.There is a positive relationship between GDP and risk of PCP diagnosis. Although failure to diagnose infection in poorer countries may contribute to this, we also hypothesise that poverty exposes at-risk patients to a wide range of infections and that the relatively non-pathogenic P. jirovecii is therefore under-represented. As LMIC develop economically they eliminate the conditions underlying transmission of virulent infection: P. jirovecii, ubiquitous in all settings, then becomes a greater relative threat.
url http://europepmc.org/articles/PMC3732248?pdf=render
work_keys_str_mv AT davidmlowe pneumocystisjiroveciipneumoniaintropicalandlowandmiddleincomecountriesasystematicreviewandmetaregression
AT molebogengxrangaka pneumocystisjiroveciipneumoniaintropicalandlowandmiddleincomecountriesasystematicreviewandmetaregression
AT fabianagordon pneumocystisjiroveciipneumoniaintropicalandlowandmiddleincomecountriesasystematicreviewandmetaregression
AT chrisdjames pneumocystisjiroveciipneumoniaintropicalandlowandmiddleincomecountriesasystematicreviewandmetaregression
AT robertfmiller pneumocystisjiroveciipneumoniaintropicalandlowandmiddleincomecountriesasystematicreviewandmetaregression
_version_ 1724754777740410880